BIB icon

ProShares Ultra NASDAQ Biotechnology

30 hedge funds and large institutions have $14.8M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.53%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
5
Reduced
10
Closed
8
Calls
$7.46M
Puts
$4.16M
Net Calls
+$3.3M
Net Calls Change
+$112K